Marant Micallef, Claire
Belhassen, Manon
Ader, Florence
Martinez, Valeria
Van Ganse, Eric
Bérard, Marjorie
Née, Mélanie
Dziadzko, Mikhail
Aubrun, Frédéric
Funding for this research was provided by:
ANR (ANR-21-COVR-0019-01, ANR-21-COVR-0019-01, ANR-21-COVR-0019-01, ANR-21-COVR-0019-01)
Fondation de France
Fondation Apicil
Article History
Received: 21 May 2024
Accepted: 20 January 2025
First Online: 27 January 2025
Declarations
:
: This study was approved by the ethic committee of the French Health Data Hub (no. 4653731, 2021/07/08). It was conducted using anonymized data and approved by the ethics committee of the National Informatics and Liberty Committee (CNIL, no. 921290, 2021/07/19). This study was registered on clinicaltrials.gov under the number NCT05073328.The data used were secondary data from the French healthcare claims database (SNDS). This is an anonymized database; thus we did not have access to patients to request their consent to participate. However, the persons concerned wishing to assert their rights should make a request to their health insurance to attachment (CPAM), in accordance with article 111 of the implementing decree of the Data Protection Act (- donnee).
: Not applicable.
: The authors declare no competing interests.